BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14503973)

  • 21. Gonadotropin secretion in patients with gonadal dysgenesis.
    Dokumov S; Milanov S
    Endocrinologie; 1976; 14(3):229-32. PubMed ID: 973112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine and cytogenetic studies in a patient with Turner's phenotype and a ring chromosome.
    Boyar RM; Wu RH; Liao PY; Finkelstein JW
    J Clin Endocrinol Metab; 1977 Feb; 44(2):340-5. PubMed ID: 320222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Spontaneous Puberty in Turner Syndrome Based on Mid-Childhood Gonadotropin Concentrations, Karyotype, and Ovary Visualization: A Longitudinal Study.
    Hankus M; Soltysik K; Szeliga K; Antosz A; Drosdzol-Cop A; Wilk K; Zachurzok A; Malecka-Tendera E; Gawlik AM
    Horm Res Paediatr; 2018; 89(2):90-97. PubMed ID: 29275408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonographic appearance of ovaries and gonadotropin secretions as prognostic tools of spontaneous puberty in girls with Turner's syndrome.
    Matarazzo P; Lala R; Artesani L; Franceshini PG; De Sanctis C
    J Pediatr Endocrinol Metab; 1995; 8(4):267-74. PubMed ID: 8821904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent decline in age at breast development: the Copenhagen Puberty Study.
    Aksglaede L; Sørensen K; Petersen JH; Skakkebaek NE; Juul A
    Pediatrics; 2009 May; 123(5):e932-9. PubMed ID: 19403485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine features of pubertal development in females with mental retardation.
    Cento RM; Ciampelli M; Proto C; Le Donne M; Romano C; Lanzone A
    Gynecol Endocrinol; 2001 Jun; 15(3):178-83. PubMed ID: 11447728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and puberty in Turner's syndrome.
    Bertelloni S; Baroncelli GI; Fruzzetti F; Spinelli C; Simi P; Saggese G
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():307-15. PubMed ID: 12729409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial carcinoma in 45,X Turner's syndrome without hormone replacement therapy.
    Matsui H; Ishii J; Onodera T; Takano H; Seki K; Sekiya S
    Gynecol Oncol; 1997 Jun; 65(3):548-52. PubMed ID: 9190993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary tumor and low gonadotropins in a patient with Turner's syndrome.
    Mermilliod JA; Gatchair-Rose A; Svec F
    J La State Med Soc; 1995 Dec; 147(12):540-3. PubMed ID: 8543891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Turner's syndrome: growth, endocrinological study and other aspects].
    Vázquez Alvarez J; Fernández Toral J; Martín Muñiz C; Salmerón Alvarez M; Roca Martínez A; de la Fuente Ciruelas P
    An Esp Pediatr; 1997 Apr; 46(4):357-61. PubMed ID: 9214227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nonmosaic 45,X karyotype in a mother with Turner's syndrome and in her daughter.
    Cools M; Rooman RP; Wauters J; Jacqemyn Y; Du Caju MV
    Fertil Steril; 2004 Oct; 82(4):923-5. PubMed ID: 15482770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytogenetic and clinical findings and follicle-stimulating hormone levels in girls with Turner's syndrome].
    Zdravković D; Joksimović I; Banićević M; Garzicić B; Nedeljković V; Subotić Z
    Srp Arh Celok Lek; 1987 Apr; 115(4):407-20. PubMed ID: 3152039
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytogenetic study on Turner's syndrome].
    Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 1984 Jan; 19(1):18-22. PubMed ID: 6430656
    [No Abstract]   [Full Text] [Related]  

  • 34. [Turner's syndrome and procreation. Ovarian function and Turner's syndrome].
    Pienkowski C; Menendez M; Cartault A; Lorenzini F; Lesourd F; Tauber M
    Gynecol Obstet Fertil; 2008 Oct; 36(10):1030-4. PubMed ID: 18815067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Turner's syndrome with estrogen.
    Levine LS
    Pediatrics; 1978 Dec; 62(6 Pt 2):1178-83. PubMed ID: 724356
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty.
    Conte FA; Grumbach MM; Kaplan SL; Reiter EO
    J Clin Endocrinol Metab; 1980 Jan; 50(1):163-8. PubMed ID: 6985614
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome.
    Gawlik A; Malecka-Tendera E
    Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):173-7. PubMed ID: 18227816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of hormone replacement therapy on lipid metabolism in patients with premature ovarian failure and Turner's syndrome].
    Yahata T; Kurabayashi T; Kato R; Yamamoto Y; Fujimaki T; Yasuda M; Oda K; Yoshizawa H; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1197-204. PubMed ID: 7844437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [45,X lymphocyte karyotype in a woman with functioning ovaries (author's transl)].
    Friedrich F; Breitenecker G; Golob E
    Wien Klin Wochenschr; 1974 Mar; 86(6):148-51. PubMed ID: 4439947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.
    Houk CP; Kunselman AR; Lee PA
    Pediatrics; 2009 Jun; 123(6):e1059-63. PubMed ID: 19482738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.